Gland Pharma Limited (GLAND) — Financial Flexibility Index
Gland Pharma Limited (GLAND) has a Financial Flexibility Index of 0.35x as of September 2025. Free cash flow of Rs7.87 Billion (operating CF Rs5.93 Billion minus capex Rs1.94 Billion) represents 0% of total liabilities (Rs22.37 Billion). Check Gland Pharma Limited strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Gland Pharma Limited Financial Flexibility Index (2017–2026)
Historical Financial Flexibility Index trend for Gland Pharma Limited across 10 annual periods. See GLAND net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Gland Pharma Limited (2017–2026)
Year-by-year free cash flow to debt coverage for Gland Pharma Limited. For the full company profile including market capitalisation, see Gland Pharma Limited (GLAND) total market value.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.80x | Rs17.22 Billion | Rs12.31 Billion | Rs21.53 Billion | ▲ +27.7% |
| 2025 | 0.63x | Rs12.99 Billion | Rs9.15 Billion | Rs20.74 Billion | ▼ -12.5% |
| 2024 | 0.72x | Rs13.87 Billion | Rs9.97 Billion | Rs19.37 Billion | ▼ -0.2% |
| 2023 | 0.72x | Rs5.87 Billion | Rs3.64 Billion | Rs8.19 Billion | ▼ -63.1% |
| 2022 | 1.94x | Rs13.13 Billion | Rs7.91 Billion | Rs6.76 Billion | ▲ +38.1% |
| 2021 | 1.41x | Rs8.34 Billion | Rs6.05 Billion | Rs5.93 Billion | ▼ -30.9% |
| 2020 | 2.04x | Rs8.96 Billion | Rs7.01 Billion | Rs4.40 Billion | ▲ +319.7% |
| 2019 | 0.49x | Rs3.21 Billion | Rs1.85 Billion | Rs6.62 Billion | ▼ -12.3% |
| 2018 | 0.55x | Rs2.87 Billion | Rs2.02 Billion | Rs5.19 Billion | ▼ -64.1% |
| 2017 | 1.54x | Rs5.93 Billion | Rs4.76 Billion | Rs3.84 Billion | — |